Immunai raises $60 million to analyze the immune system with AI
February 12, 2021
Immunai, a startup developing an AI platform to analyze the human immune system, today announced that it raised $60 million. The company says it will use the funds to broaden its functional genomics capabilities and help its partners prioritize, discover, and develop new therapies and drug combinations.
Emerging treatments like gene cell therapies and cancer immunotherapies promise to…